Dietary milled flaxseed and flaxseed oil improve N-3 fatty acid status and do not affect glycemic control in individuals with well-controlled type 2 diabetes
- PMID: 20595648
- DOI: 10.1080/07315724.2010.10719819
Dietary milled flaxseed and flaxseed oil improve N-3 fatty acid status and do not affect glycemic control in individuals with well-controlled type 2 diabetes
Abstract
Objective: To determine the effects of dietary consumption of milled flaxseed or flaxseed oil on glycemic control, n-3 fatty acid status, anthropometrics, and adipokines in individuals with type 2 diabetes.
Design: Thirty-four participants were randomized into a parallel, controlled trial.
Subjects: The participants were adults with type 2 diabetes (age 52.4 +/- 1.5 years, body mass index 32.4 +/- 1.0 kg/m(2), n = 17 men and 17 women).
Interventions: Participants consumed a selection of bakery products containing no flax (control group [CTL], n = 9), milled flaxseed (FXS, n = 13; 32 g/d), or flaxseed oil (FXO, n = 12; 13 g/d) daily for 12 weeks. The FXS and FXO groups received equivalent amounts of alpha-linolenic acid (ALA; 7.4 g/day).
Measures of outcome: The primary outcome measures were fasting plasma hemoglobin A(1c), glucose, insulin, and phospholipid fatty acid composition. The secondary outcome measures were fasting circulating leptin and adiponectin, as well as body weight, body mass index, and waist circumference. Dietary intake assessment and calculations for homeostasis model assessment for insulin resistance and quantified insulin sensitivity check were also completed.
Results: The FXS and FXO groups had increases in plasma phospholipid n-3 fatty acids (ALA, eicosapentaenoic acid [EPA], or decosapentaenoic acid [DPA], but not docosahexaenoic acid), and the FXO group had more EPA and DPA in plasma phospholipids compared to the FXS group. All groups had similar caloric intakes; however, the CTL group experienced a 4% weight gain compared to baseline (p < 0.05), while both flax groups had constant body weights during the study period. All other parameters, including glycemic control, were unchanged by dietary treatment.
Conclusions: Milled FXS and FXO intake does not affect glycemic control in adults with well-controlled type 2 diabetes. Possible prevention of weight gain by flax consumption warrants further investigation.
Similar articles
-
The effect of flaxseed dose on circulating concentrations of alpha-linolenic acid and secoisolariciresinol diglucoside derived enterolignans in young, healthy adults.Eur J Nutr. 2016 Mar;55(2):651-663. doi: 10.1007/s00394-015-0885-2. Epub 2015 Mar 26. Eur J Nutr. 2016. PMID: 25808116 Clinical Trial.
-
Comparative omega-3 fatty acid enrichment of egg yolks from first-cycle laying hens fed flaxseed oil or ground flaxseed.Poult Sci. 2017 Jun 1;96(6):1791-1799. doi: 10.3382/ps/pew462. Poult Sci. 2017. PMID: 28108729 Free PMC article.
-
Bioavailability of alpha-linolenic acid in subjects after ingestion of three different forms of flaxseed.J Am Coll Nutr. 2008 Apr;27(2):214-21. doi: 10.1080/07315724.2008.10719693. J Am Coll Nutr. 2008. PMID: 18689552 Clinical Trial.
-
Flaxseed and cardiovascular health.J Cardiovasc Pharmacol. 2009 Nov;54(5):369-77. doi: 10.1097/FJC.0b013e3181af04e5. J Cardiovasc Pharmacol. 2009. PMID: 19568181 Review.
-
[Biological activity of linseed oil as the source of omega-3 alpha-linolenic acid].Biomed Khim. 2004 Jan-Feb;50(1):25-43. Biomed Khim. 2004. PMID: 15108624 Review. Russian.
Cited by
-
Complementary and alternative medicine in diabetes care.Curr Diab Rep. 2012 Dec;12(6):749-61. doi: 10.1007/s11892-012-0315-2. Curr Diab Rep. 2012. PMID: 22986889 Review.
-
Flaxseed oil ameliorates alcoholic liver disease via anti-inflammation and modulating gut microbiota in mice.Lipids Health Dis. 2017 Feb 22;16(1):44. doi: 10.1186/s12944-017-0431-8. Lipids Health Dis. 2017. PMID: 28228158 Free PMC article.
-
Effects of flaxseed supplementation on erythrocyte fatty acids and multiple cardiometabolic biomarkers among Chinese with risk factors of metabolic syndrome.Eur J Nutr. 2013 Aug;52(5):1547-51. doi: 10.1007/s00394-012-0461-y. Epub 2012 Nov 23. Eur J Nutr. 2013. PMID: 23179200 Clinical Trial.
-
Interactive Effect of Probiotics Supplementation and Weight Loss Diet on Metabolic Syndrome Features in Patients With Coronary Artery Diseases: A Double-Blind, Placebo-Controlled, Randomized Clinical Trial.Am J Lifestyle Med. 2019 May 3;15(6):653-663. doi: 10.1177/1559827619843833. eCollection 2021 Nov-Dec. Am J Lifestyle Med. 2019. PMID: 34916886 Free PMC article.
-
The effect of flaxseed powder on insulin resistance indices and blood pressure in prediabetic individuals: A randomized controlled clinical trial.J Res Med Sci. 2016 Sep 1;21:70. doi: 10.4103/1735-1995.189660. eCollection 2016. J Res Med Sci. 2016. PMID: 27904615 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials